Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 24 461.0 |
96 | EP file number | EAKZ | 03 78 9562.0 |
86 | WO file number | WAKZ | PCT/GB03/05640 |
97 | EP publication number | EPN | 1575966 |
87 | WO publication number | WPN | 2004058782 |
54 | Designation/title | TI | THERAPEUTISCHE QUINAZOLIN-DERIVATE |
51 | IPC main class | ICM (ICMV) | C07F 9/6558 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07F 9/6512 (2006.01), A61K 31/675 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Dec 22, 2003 |
96 | EP application date | EAT | Dec 22, 2003 |
86 | WO application date | WAT | Dec 22, 2003 |
43 | Date of first publication | OT | Jul 15, 2004 |
| Date of publication of grant | PET | Oct 29, 2008 |
71/73 | Applicant/owner | INH | AstraZeneca AB, 15185 Södertälje, SE |
72 | Inventor | IN | MORTLOCK, Andrew, Austen, Macclesfield, Cheshire SK10 4TG, GB |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 02293240 Dec 24, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001575966 Searchable text:
EP000001575966 Original document:
EP000001575966B1 Searchable text:
EP000001575966B1 Original document:
WO002004058782 Searchable text:
WO002004058782 |
43 | Date of first publication | EVT | Jul 15, 2004 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 29, 2018 (Show all update days)(Hide all update days)- Sep 30, 2012
- Date of the first transfer into DPMAregister
|